E J Sherman Selected Research

Anemia

3/2014

Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E J Sherman Research Topics

Disease

3	Squamous Cell Carcinoma of Head and Neck 01/2018 - 03/2014
1	Virus Diseases (Viral Diseases) 06/2022
1	Infections 06/2022
1	Fatigue 10/2016
1	Neoplasms (Cancer) 10/2016
1	Pain (Aches) 10/2016
1	Adenoid Cystic Carcinoma (Cylindroma) 10/2016
1	Hypertension (High Blood Pressure) 10/2016
1	Mucositis 03/2014
1	Anemia 03/2014
1	Dehydration (Water Stress) 03/2014
1	Supraventricular Tachycardia 03/2014
1	Carcinoma (Carcinomatosis) 02/2001

Drug/Important Bio-Agent (IBA)

2	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 10/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 10/2017
2	temsirolimus FDA Link 01/2018 - 10/2017
1	ADP-Ribosylation Factor 6IBA 06/2022
1	NAV-2729IBA 06/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2017
1	Axitinib (AG 013736)IBA 10/2016
1	130-nm albumin-bound paclitaxelIBA 03/2014
1	Cetuximab (Erbitux)FDA Link 03/2014
1	Taxoids (Taxanes)IBA 03/2014
1	AndrogensIBA 02/2001
1	VA 061 (VA061)IBA 02/2001

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 10/2017
1	Radiotherapy 03/2014